Sally-Ann Williams
Business

A new Melbourne biotech incubator is on the hunt for startups with $70 million on the table

- June 29, 2023 2 MIN READ

Australia’s newest biotech incubator, Jumar Bioincubator, is seeking expressions of interest from early-stage biotech to be part of the Melbourne-based program. The $30 million incubator will connect early-stage and scaling biotech ventures with state-of-the-art facilities, infrastructure, and support to turn ideas into treatments and commercialise medical research. Jumar is a mountaineering technique where climbers receive… Read more »

Ellume Covid-19 home test
Business

Covid biotech Ellume Health placed in liquidation after rival buyer fails to pay up

- June 20, 2023 2 MIN READ

Queensland biotech company Ellume Health, which just two years ago was riding high after winning a $300 million US government Covid contract, has been placed in liquidation after a takeover offer for the failed business fell through. The Australian arm of the global business entered voluntary administration last August. It subsequently emerged that it owed… Read more »

OneVentures principal Dr Jeannie Joughin
Funding

OneVentures backs cancer biotech ImmVirX in $25 million Series B

- June 5, 2023 2 MIN READ

Sydney VC OneVentures has pledged $15 million as a cornerstone investment towards a $25 million Series B raise for life sciences startup ImmVirX. The biotech startup is developing cancer treatments using oncolytic viral immunotherapies (viruses that infect and destroy cancer cells without damaging normal cells). The remaining $10 million in the Series offered to existing… Read more »

Dr Amanda Vrselja
Other

Biotech incubator CUREator tips $12 million into 19 startups tackling global health

- June 2, 2023 3 MIN READ

Biotech incubator CUREator has allocated $12 million in venture funding to 19 projects focused on a range of global health issues, ranging from treatments for lupus, motor neurone disease, brain and ovarian cancer, and inflammatory bowel disease, as part of its second cohort. Backed by the federal government’s Medical Research Future Fund (MRFF), which invested… Read more »

R&D, science, man looking in microscope
ASX

Andrew Forrest doubles down on therapeutic ecstasy biotech Emyria

- May 1, 2023 2 MIN READ

ASX-listed biotech Emyria(ASX: EMD), which is developing psychotherapy treatments using MDMA (aka ecstacy) and psilocybin (aka magic mushrooms), has raised $2.5 million in share placement backed by existing investor Andrew Forrest through the healthtech fund Tenmile, part of his private investment group, Tattarang. The $2.5 million placement was jointly led by Perth’s Sixty Two Capital… Read more »

Hong Weng Chong
Funding

The biotech startup behind the petri dish of brain cells that played Pong just raised $15 million

- April 19, 2023 2 MIN READ

Synthetic biology startup Cortical Labs, which is developing a new kind of artificial intelligence using human brain cells, has raised USD$10 million (A$15m). The Melbourne biotech rose to prominence in October last year when it combined 800,000 brain cells with a computer chip to learn to play the video gam Pong. The project was dubbed… Read more »

Michele Stansfield
Funding

Female-founded fermentation startup Cauldron lands $10.5 million to transform how new foods and fibres are developed

- March 27, 2023 2 MIN READ

Cauldron speeds up development of new food, feedstock and fibre ingredients Its hyper-fermentation platform lowers commercial risk & production costs $10.5m Seed round led by Main Sequence + Horizons Ventures An ambitious plan to transform the way new food, feedstock and fibre ingredients are created, by using fermentation has raised $10.5 million in seed funding… Read more »

R&D, science, man looking in microscope
Funding

Medtech startups can score up to $5 million from a new incubator fund

- March 20, 2023 2 MIN READ

A new medical technology incubator program developed by the Medical Research Future Fund (MRFF) during the former Coalition government will offer up to $5 million in funding for early-stage medical research projects with commercial potential. The $50 million BioMedtech Incubator program is being backed by the MRFF and the Medical Research Commercialisation Initiative. Responsibility for… Read more »

23Strands Genome sequencing
Other tech

Healthtech startup 23Strands is taking genomics mainstream to transform medicine

- February 6, 2023 2 MIN READ

Biotech startup 23Strands is planning to take genomics into mainstream healthcare through its cutting-edge research and innovations in bioinformatics, scientific literature analysis, and clinical insights based on whole genome sequencing (WGS). A human body contains around 3 billion pairs of genes. But the function of every gene is still not known. Genome sequencing links genes… Read more »

Ferronova CEO Stewart Bartlett
Funding

South Australian biotech startup Ferronova banks $11 million to tackle cancer treatment

- January 23, 2023 2 MIN READ

Adelaide biotech company Ferronova has raised $8 million from investors topped up with a $3 million research grant from the federal government for its nanoparticle platform to help surgeons to locate and remove malignant cells in stomach and brain cancers. Irish healthtech venture Renew Pharmaceuticals led the raise, supported by existing backers Uniseed and Artesian… Read more »

Funding

Rapid blood infection detection scale-up Microbio banks $3.5 million

- December 8, 2022 2 MIN READ

Queensland biotechnology scale-up Microbio has raised $3.5 million as it looks to roll out its rapid bloodstream infection tests across international markets. Microbio CEO Paul Carboon said existing and new investors, including eminent scientist and Gardasil co-inventor Professor Ian Frazer, had shown strong support for the biotech as it gains regulatory approval in multiple countries… Read more »

Climate Tech

Why waiting for biotech to solve climate change problems could make things worse for the environment, rather than better

- November 29, 2022 3 MIN READ

The world is under growing pressure to find sustainable options to cut emissions or lessen the impacts of climate change. Technology entrepreneurs from around the globe claim to have the solutions – not just yet, but soon. The biotech sector in particular is now using climate change as an urgent argument for more government funding,… Read more »